COMPARE - RESULTS OF A RANDOMISED STUDY TO ASSESS THE RENAL SAFETY AND EFFICACY OF IBANDRONATE AND ZOLEDRONATE IN MULTIPLE MYELOMA PATIENTS

被引：0
|
作者：
Knauf, U. [1 ]
Bergner, R. [2 ]
Kropff, M. [2 ]
Poenisch, W. [3 ]
Kiewitz, C. [4 ]
Goldschmidts, H. [5 ]
机构：
[1] Onkol Gemeinschaftspraxis, Frankfurt, Germany
[2] Med Klin A, Ludwigshafen, Germany
[3] Med Klin 2, Leipzig, Germany
[4] Roche Pharma AG, Grenzach Wyhlen, Germany
[5] Med Klin 5, Heidelberg, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0961
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment
    Frank Bridoux
    Nianhang Chen
    Stephane Moreau
    Bertrand Arnulf
    Eric Moumas
    Julie Abraham
    Estelle Desport
    Arnaud Jaccard
    Jean Paul Fermand
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 173 - 182
  • [22] EFFICACY AND SAFETY OF LENALIDOMIDE IN THE TREATMENT OF MULTIPLE MYELOMA WITH RENAL INSUFFICIENCY
    Bernal, L.
    Bonafonte, E.
    Izquierdo, I.
    Aules, A.
    Malo, M.
    Olave, M.
    Azaceta, G.
    Gutierrez, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 628 - 629
  • [23] Pharmacokinetics, Efficacy and Safety of Lenalidomide (Len) in Myeloma Patients with Renal Impairment: Results From the Prospective Study "REVIR"
    Bridoux, Frank
    Arnulf, Bertrand
    Moreau, Stephane
    Moumas, Eric
    Chen, Nianhang
    Alakl, May
    Desport, Estelle
    Neel, Valerie
    Jaccard, Arnaud
    Fermand, Jean Paul
    BLOOD, 2011, 118 (21) : 1265 - 1266
  • [24] Long-term treatment with ibandronate: Influence on renal function in multiple myeloma patients
    Breuer, J.
    Uppenkamp, M.
    Bergner, R.
    BONE, 2010, 47 : S303 - S303
  • [25] Dose escalation of ibandronate in patients with multiple myeloma and end-stage renal disease - an open label study
    Henrich, D
    Bergner, R
    Hoffmann, M
    Uppenkamp, M
    BONE, 2006, 38 (03) : S74 - S74
  • [26] Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA
    Morabito, Fortunato
    Gentile, Massimo
    Ciolli, Stefania
    Petrucci, Maria T.
    Galimberti, Sara
    Mele, Giuseppe
    Casulli, Antonio F.
    Mannina, Donato
    Piro, Eugenio
    Pinotti, Graziella
    Palmieri, Salvatore
    Catalano, Lucio
    Callea, Vincenzo
    Offidani, Massimo
    Musto, Pellegrino
    Bringhen, Sara
    Baldini, Luca
    Tosi, Patrizia
    Di Raimondo, Francesco
    Boccadoro, Mario
    Palumbo, Antonio
    Cavo, Michele
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (03) : 223 - 228
  • [27] EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS INJECTION OF BORTEZOMIB IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
    Fu, C.
    Liu, H.
    Wu, D.
    Xue, S.
    Li, W.
    Wu, Q.
    Gu, B.
    Jin, S.
    Zhu, X.
    Zhao, S.
    Xin, X.
    Ma, L.
    Sun, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S452 - S452
  • [28] Patients with multiple myeloma are more likely to experience renal impairment with zoledronic acid than with ibandronate
    Antras, L.
    Weide, R.
    Koeppler, H.
    Smith, M.
    Green, J.
    Neary, M.
    Wintfeld, N.
    Duh, M.
    CANCER TREATMENT REVIEWS, 2006, 32 : S35 - S35
  • [29] Ibandronate for the treatment of hypercalcemia or nephrocalcinosis in patients with multiple myeloma and acute renal failure: Case reports
    Henrich, Dirk
    Hoffmann, Martin
    Uppenkamp, Michael
    Bergner, Raoul
    ACTA HAEMATOLOGICA, 2006, 116 (03) : 165 - 172
  • [30] Efficacy and Safety of Bortezomib Based Regimens Retreatment in Relapsed Multiple Myeloma Patients: Results from a Retrospective Study.
    Wu, Wenjun
    Zheng, Gaofeng
    Han, Xiaoyan
    Zhao, Yi
    He, Donghua
    Yang, Yang
    He, Jingsong
    Zheng, Weiyan
    Sun, Jie
    Shi, Jimin
    Wei, Guoqing
    Huang, He
    Cai, Zhen
    BLOOD, 2015, 126 (23)
12345